Concepedia

Thilo Blüthner

TB

Statistics

Publications

1

Citations

54

H-Index

1

Active since

2006

Affiliations

Leipzig University(Current)

Thilo Blüthner is an author at Leipzig University specializing in tyrosine kinase inhibitors, oncogenes, and oncogenic signaling pathways.

Publications per year

2006–2006

1

Publications

1

Novel targeted approaches to treating biliary tract cancer: the dual epidermal growth factor receptor and ErbB-2 tyrosine kinase inhibitor NVP-AEE788 is more efficient than the epidermal growth factor receptor inhibitors gefitinib and erlotinib

Marcus Wiedmann, Jürgen Feisthammel, Thilo Blüthner et al. · Anti-Cancer Drugs · 2006 · 54 citations

Medicine, Oncology, Pharmacology +17

1–1 of 1